Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. (ALDX) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 122 transactions totaling $81.8M, demonstrating a bullish sentiment with $68.9M in net insider flow. The most recent transaction on Aug 13, 2025 involved a purchase of 2,500 shares valued at $13.3K.
ALDX Insider Activity Summary
Who Is Buying ALDX Stock?
No significant insider buying has been recorded for ALDX in the recent period.
Who Is Selling ALDX Stock?
No significant insider selling has been recorded for ALDX in the recent period.
Is Aldeyra Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ALDX is bullish with an Insider Alignment Score of 92/100 and a net flow of $68.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ALDX Frequently Asked Questions
Understanding ALDX Insider Activity
Insider trading at Aldeyra Therapeutics, Inc. (ALDX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading ALDX stock, having executed 122 transactions in the past 90 days. The most active insider is Life Sciences Master Fund Ltd Perceptive (Executive), who has made 14 transactions totaling $32.8M.
Related Tools
Track Aldeyra Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ALDX file new Form 4 transactions